SCHEMBL19253879

SCHEMBL19253879

O=C(O)c1ccc2[nH]c(C(Cc3ccccc3)c3ccc(Br)cn3)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HDAC6 Q9UBN7 1/20 0.38
MLKL Q8NB16 2/20 0.37
S1PR2 O95136 2/20 0.37
S1PR4 O95977 2/20 0.37
S1PR3 Q99500 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
CRHBP P24387 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
CRHR2 Q13324 1/20 0.37
AAK1 Q2M2I8 1/20 0.36
MAPK1 P28482 1/20 0.36
LMNA P02545 1/20 0.36
MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17477819 0.89 SMN1; SMN2 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17480682 0.87 SLC7A5 (0.38) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17480684 0.84 LMNA (0.39) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL17480702 0.81 F11 (0.40) MLKLOPRM1OPRD1CTDSP1
SCHEMBL392474 0.77 ROCK2 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20953989 0.75 F11 (0.57)
SCHEMBL20953990 0.75 F11 (0.57)
SCHEMBL19253880 0.73 MMP2 (0.38) MAPTMEN1HTTKMT2AAAK1
SCHEMBL7404382 0.71 F2 (0.48) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7406090 0.71 F10 (0.47) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3180327-B1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME (US) 2019-05-08 EP disclosed
US-10011585-B2 Factor XIa inhibitors MERCK SHARP & DOHME CORP. (US) 2018-07-03 US disclosed
US-20170240523-A1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170240523-A1 FACTOR XIa INHIBITORS F11, SERPINC1, TFPI CYP1A2 1032/4885CYP3A4 1625/4885CYP2D6 3248/4885
US-10011585-B2 Factor XIa inhibitors F11, SERPINC1, TFPI CYP1A2 1032/4885CYP3A4 1625/4885CYP2D6 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.